Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,083 | 149,099 | 95,287 | 81,948 | 51,269 |
| Marketable Securities | 541,740 | 518,141 | 454,378 | 548,780 | 606,922 |
| Receivables | 9,348 | 8,804 | 35,936 | 4,574 | 48,746 |
| Inventories | 843 | 413 | N/A | N/A | N/A |
| TOTAL | $623,782 | $708,663 | $620,663 | $660,075 | $724,198 |
| Non-Current Assets | |||||
| PPE Net | 7,613 | 7,855 | 7,397 | 3,912 | 2,348 |
| Other Non-Current Assets | 21,156 | 21,845 | 21,321 | 18,438 | 17,218 |
| TOTAL | $28,769 | $29,700 | $28,718 | $22,350 | $19,566 |
| Total Assets | $652,551 | $738,363 | $649,381 | $682,425 | $743,764 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 4,337 | 3,112 | 1,921 |
| Accounts payable and accrued liabilities | 7,043 | 5,017 | 66,788 | 52,931 | 45,094 |
| Accrued Expenses | 45,466 | 61,697 | N/A | N/A | N/A |
| Other current liabilities | 47,704 | 48,983 | 48,750 | 49,435 | 40,846 |
| TOTAL | $101,496 | $116,974 | $121,304 | $107,174 | $89,766 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,749 | 9,711 | 5,336 | 6,509 | 7,650 |
| Other Non-Current Liabilities | 433,423 | 437,543 | 280,199 | 263,256 | 281,942 |
| TOTAL | $443,172 | $447,254 | $285,535 | $269,765 | $289,592 |
| Total Liabilities | $544,668 | $564,228 | $406,839 | $376,939 | $379,358 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,774 | 88,330 | 87,018 | 86,797 | 86,575 |
| Common Shares | 9 | 9 | 9 | 9 | 8 |
| Retained earnings | -1,247,421 | -1,174,088 | -1,093,089 | -1,018,973 | -952,851 |
| Other shareholders' equity | -380 | 1,024 | 918 | 711 | 974 |
| TOTAL | $107,883 | $174,135 | $242,542 | $305,486 | $364,406 |
| Total Liabilities And Equity | $652,551 | $738,363 | $649,381 | $682,425 | $743,764 |